Valid for Submission
T86.810 is a billable diagnosis code used to specify a medical diagnosis of lung transplant rejection. The code T86.810 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code T86.810 might also be used to specify conditions or terms like accelerated rejection of lung transplant, acute rejection of lung transplant, chronic rejection of lung transplant, hyperacute rejection of lung transplant, lung transplant rejection , transplanted lung present, etc.
The appropriate 7th character is to be added to each code from block Complications of transplanted organs and tissue (T86). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code T86.810 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Accelerated rejection of lung transplant
- Acute rejection of lung transplant
- Chronic rejection of lung transplant
- Hyperacute rejection of lung transplant
- Lung transplant rejection
- Transplanted lung present
Diagnostic Related Groups - MS-DRG Mapping
Convert T86.810 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code T86.810 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Information for Patients
A lung transplant removes a person's diseased lung and replaces it with a healthy one. The healthy lung comes from a donor who has died. Some people get one lung during a transplant. Other people get two.
Lung transplants are used for people who are likely to die from lung disease within 1 to 2 years. Their conditions are so severe that other treatments, such as medicines or breathing devices, no longer work. Lung transplants most often are used to treat people who have severe
- Cystic fibrosis
- Idiopathic pulmonary fibrosis
- Alpha-1 antitrypsin deficiency
- Pulmonary hypertension
Complications of lung transplantation include rejection of the transplanted lung and infection.
NIH: National Heart, Lung, and Blood Institute
- Lung transplant (Medical Encyclopedia)
[Learn More in MedlinePlus]